
BFLY AI Price Prediction
Track BFLY's AI-powered predictions, market trends, and investment insights.
You don't hold BFLY in your mock portfolio yet.
Track BFLY's AI-powered predictions, market trends, and investment insights.
You don't hold BFLY in your mock portfolio yet.
Upgrade to see the full Evidence Stack
What Changed, Why Now, and Risk Flags — available on the Investor plan and above
Get StartedButterfly Network remains unprofitable, as indicated by its negative EPS of -0.30 and a corresponding negative PE ratio of -14.90. This suggests the company is still in an investment and growth phase with no clear line of sight to consistent earnings. Without positive net income or profitability ratios, the equity story is still largely speculative and dependent on future execution.
The stock trades at $4.47, about 39% above its 200-day moving average of $3.21, indicating a strong intermediate-term uptrend despite a recent 16.1% pullback over the last month. The elevated price versus the 200-day average suggests prior bullish momentum, but the recent drawdown points to rising selling pressure or profit-taking. Without an explicit RSI reading, the mixed signals lean toward a consolidation phase rather than a clear bullish or bearish trend.
Website traffic of roughly 141k monthly visitors indicates a meaningful but niche level of digital engagement, with no clear growth trend provided. A 7.7% month-over-month decline in job openings suggests some moderation in hiring, which can signal tighter cost control but also potentially slower expansion. Social media metrics are broadly stable to slightly positive, with modest follower growth on Instagram, Facebook, and YouTube offsetting a very small decline on Twitter/X, pointing to steady but not explosive brand engagement.
Overall, Butterfly Network presents a mixed picture: the company is still unprofitable and carries typical early-stage risk, but the stock trades above its 200-day moving average and shows only a recent pullback after prior strength. Alternative data points to stable engagement and modest hiring, consistent with a company managing growth and costs rather than aggressively expanding. Taken together, the signals support a neutral stance, with upside dependent on future execution and a clearer path to profitability.
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals.
Butterfly Network (BFLY) is currently trading at $4.60 on the NYSE, posting a modest intraday gain of 1.1% on volume of over 3.5 million shares. The company carries a market capitalization of approximately $1.2 billion, a notable valuation for a medical devices firm still navigating the path to profitability. Butterfly Network operates at the intersection of hardware and digital health, commercializing its handheld ultrasound systems — the iQ and iQ+ — alongside its enterprise-facing Blueprint platform, which integrates into hospital clinical and administrative infrastructure across the U.S. and internationally.
TrendEdge's AI model assigns BFLY a score of 3 out of 10, signaling a predominantly bearish outlook based on current market signals. A score this low typically reflects weak momentum, unfavorable risk-adjusted positioning, or deteriorating technical structure relative to sector peers. While the 1.1% single-day uptick offers a minor positive data point, it is insufficient to shift the overall signal. Investors should note that a low AI score does not predict a specific price target, but rather synthesizes available momentum, volume, and trend data into a unified risk signal — and for BFLY right now, that signal skews cautious.
Looking ahead, the key catalysts for BFLY center on adoption rates of its iQ+ device and the scalability of the Butterfly Blueprint enterprise platform. Expanding hospital system integrations could meaningfully improve revenue visibility. Key risks include continued cash burn typical of growth-stage medtech companies, competitive pressure from established ultrasound manufacturers, and the pace of reimbursement coverage expansion. Investors should monitor quarterly revenue trends and gross margin progression as leading indicators of whether the business model is gaining durable traction.
Unlock comprehensive alternative data signals to make better investment decisions
TrendEdge provides tools and data for research and educational purposes only and does not provide investment advice or personal recommendations.
Web Traffic
125,898
Twitter Followers
23,381
Instagram Followers
36,718
YouTube Subscribers
31,000
Job Postings
22
LinkedIn Employees
413
News Mentions
0
Key Metrics